Categories AlphaGraphs, Earnings, Retail

KB Home Q4 profit jumps 15%, beats estimates

Homebuilder KB Home (KBH) reported a 15% jump in earnings for the fourth quarter helped by the reduction in federal corporate income tax rate. The bottom exceeded analysts’ expectations, while the top line came in line with consensus. Following this, the stock inched up over 4% in the after-market session.

Net income for the quarter grew 15% to $96.8 million, and earnings increased 14% to $0.96 per share. The recent tax act lowered the effective tax rate by 36 basis points. However, revenue fell 4% to $1.35 billion due to lower homebuilding revenue.

KB Home Q4 2018 Earnings Infographic

The company delivered a total of 3,389 homes during the quarter, up 1.5% compared to last year. The average selling price of a single residential unit declined 5% to $395,200 due primarily to a shift in geographic mix of homes delivered.

Net orders for the fourth quarter fell 12.3% to 2,013, and net order value dropped 21.1% to $738.3 million. The number of homes in ending backlog decreased 7% to 4,108 and ending backlog value plunged 14% to $1.43 billion. The decrease in backlog value reflects fewer homes in backlog and the lower average selling price of those homes due to a shift in geographic mix.

The company had total liquidity of $1.05 billion as of November 30, 2018, including cash and cash equivalents of $574.4 million. Inventories increased by 10% to $3.58 billion. Stockholders’ equity increased by $161.2 million to $2.09 billion.

Shares of KB Home ended Wednesday’s regular session up 4.12% at $21.98 on the NYSE. The stock has fallen over 35% in the past year and over 1% in the past three months.

 

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

 

 

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top